Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to learn if the novel biomarker Heat shock protein 47 (HSP47) can be used as a prognostic marker for vascular disease in people with acute venous thromboembolis...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Aarhus
Collaborators
NCT07015905 · Venous Thromboembolism (VTE)
NCT07140211 · Venous Thromboembolism (VTE), Postpartum
NCT07360899 · ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), and more
NCT07310693 · Venous Thromboembolism (VTE), Occult Cancer
NCT07288632 · Venous Thromboembolism (VTE), NSCLC (Advanced Non-small Cell Lung Cancer)
Aarhus University Hospital
Aarhus, Central Region
Deutsches Herzzentrum de Charité
Berlin, State of Berlin
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions